General Information of the Compound
Compound ID |
CP0071969
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
Menthol
Show/Hide
|
||||||||||||||||||
Synonyms |
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
2-Isopropyl-5-methylcyclohexanol
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
Cis-1 ,3-trans-1,4-(+-)-menthol
Cis-1,3-trans-1,4-(+-)-menthol
D,l-Menthol
D-(-)-Menthol
D-Menthol
D-Neomenthol
D-p-Menthan-3-ol
Dl-3-p-Menthanol
Dl-Menthol
Dl-Menthol (JP15)
Fisherman's friend lozenges
Fisherman's friendlozenges (TN)
Headache crystals
Hexahydrothymol
L-(-)-Menthol
L-Menthol
L-Menthol (JP15)
L-Menthol (TN)
L-Menthol (natural)
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
M0321
M0545
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
NOOLISFMXDJSKH-KXUCPTDWBX
Neoisomenthol
P-Menthan-3-ol
Peppermint camphor
RACEMIC MENTHOL U.S.PRac-Menthol
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
Tra-kill tracheal mite killer
U.S.P. Menthol
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C10H20O
|
||||||||||||||||||
Molecular Weight |
156.269
|
||||||||||||||||||
Canonical SMILES |
CC(C)C1CCC(C)CC1O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3
Show/Hide
|
||||||||||||||||||
InChIKey |
NOOLISFMXDJSKH-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
20747-49-3
1490-04-6
491-02-1
15356-70-4
63975-60-0
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04242, Transient receptor potential cation channel subfamily A member 1
Protein ID: PT03065, Transient receptor potential cation channel subfamily M member 8
Clinical Information about the Compound